PROMIS-PF4a

PROMIS-PF4a lowers the risk of mortality in humans (HR 0.96, 95% CI 0.95-0.98).

Humanskidney failure undergoing hemodiafiltration or hemodialysismedian follow-up of 30 monthsn = 1,360

Self-Reported Versus Performance-Based Measures of Physical Function and Mortality Among Patients With Kidney Failure: A Cohort Analysis of the CONVINCE Trial · American journal of kidney diseases : the official journal of the National Kidney Foundation · 21 Sep 2026